Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Squamous Non-Small Cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03674567
What this trial is testing

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

Who this might be right for
Advanced Cancer
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 323
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT06974604
What this trial is testing

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

Who this might be right for
Breast NeoplasmsLung Neoplasms
Brown University 60
Early research (Phase 1)Ended earlyNCT06974734
What this trial is testing

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Who this might be right for
Carcinoma, Non Small Cell LungCarcinoma, Pancreatic DuctalMalignant Melanoma+1 more
Pfizer 8
Early research (Phase 1)Ended earlyNCT02376699
What this trial is testing

Safety Study of SEA-CD40 in Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellHodgkin Disease+17 more
Seagen Inc. 159
Testing effectiveness (Phase 2)Study completedNCT01469000
What this trial is testing

Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non Small Cell Lung
Eli Lilly and Company 195
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Early research (Phase 1)Study completedNCT03708328
What this trial is testing

A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid TumorsMetastatic MelanomaNon-small Cell Lung Cancer (NSCLC)+2 more
Hoffmann-La Roche 134
Large-scale testing (Phase 3)Active Not RecruitingNCT05048797
What this trial is testing

Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca 454
Testing effectiveness (Phase 2)Study completedNCT02264210
What this trial is testing

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

Who this might be right for
Lung NeoplasmsSquamous Cell Lung CancerAdenocarcinoma of the Lung+4 more
Sun Yat-sen University 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT05781308
What this trial is testing

Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 156
Early research (Phase 1)Study completedNCT03552718
What this trial is testing

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

Who this might be right for
Colorectal CancerBreast CancerHead and Neck Squamous Cell Carcinoma+4 more
NantBioScience, Inc. 5
Early research (Phase 1)Study completedNCT02520778
What this trial is testing

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Non-Small Cell Cancer AJCC v7+3 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)WithdrawnNCT05566223
What this trial is testing

CISH Inactivated TILs in the Treatment of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungMetastatic Non Small Cell Lung CancerStage IV Non-small Cell Lung Cancer+3 more
Intima Bioscience, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00545948
What this trial is testing

Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Duke University 31
Large-scale testing (Phase 3)Study completedNCT00002550
What this trial is testing

Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 429
Large-scale testing (Phase 3)Ended earlyNCT01377376
What this trial is testing

A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib

Who this might be right for
Non-small-cell Lung Cancer
Kyowa Kirin Co., Ltd.
Large-scale testing (Phase 3)Ended earlyNCT00673049
What this trial is testing

Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer

Who this might be right for
Carcinoma, Large CellCarcinoma, Non-Small-Cell LungCarcinoma, Squamous Cell+1 more
Pfizer 583
Testing effectiveness (Phase 2)Ended earlyNCT03430063
What this trial is testing

REGN2810 and Ipilimumab in Patients With Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Carcinoma
Regeneron Pharmaceuticals 28
Testing effectiveness (Phase 2)Looking for participantsNCT07730021
What this trial is testing

ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Astellas Pharma Global Development, Inc. 392
Next Page